Analyst Research Report Snapshot


Meda AB






26 Jan 2015





Companies referenced:

Available for Immediate Download

Meda AB - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Meda AB required for business and competitor intelligence needs - Intelligence on Meda AB’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Meda AB, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Meda is a Sweden-based specialty pharmaceutical company. The company is engaged in manufacturing and distributing of specialty products, over the counter (OTC) (nonprescription products), and branded generics in the therapy areas of respiratory, dermatology, cardiology, pain and inflammation, and gastroenterology. Meda operates in Europe, North America, Australia, Russia and Asia-Pacific regions. It is headquartered in Solna, Sweden and employs around 3,062 people. The company recorded revenues of SEK13,114 million (approximately $2,014 million) in the fiscal year ended December 2013, an increase of 0.9% over 2012. The company's operating profit was SEK1,548 million (approximately $237.7 million) in fiscal 2013, a decrease of 14% compared to 2012. Its net profit was SEK807 million (approximately $123.9 million) in fiscal 2013, a decrease of 33% compared to 2012. Reasons to Purchase: - Gain understanding of Meda AB the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Meda AB as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Meda AB your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.